Mp78-07 Clinical Characteristics Associated With Early Progression or Long-Term Response From the Phase Ii Imvigor210 Study: Atezolizumab in Locally Advanced or Metastatic Urothelial Carcinoma

Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.2555

Related search